{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:24:30Z","timestamp":1784557470047,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Following surgery for esophageal cancer, approximately half of patients develop disease recurrence. Analyzing recurrence site, timing, and their impact on postrecurrence survival can guide refinements in postoperative surveillance and therapy. This study aimed to describe the pattern and timing of esophageal cancer recurrence and assess survival patterns by recurrence location.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included patients from the ENSURE study who underwent resection for esophageal and junctional adenocarcinoma between 2009 and 2015 across 20 centers in Europe and Canada. Only patients with disease recurrence were included in the final analysis. Sites of first recurrence were stratified into different groups and survival outcomes postrecurrence detection were estimated using Kaplan-Meier curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 3,299 patients who underwent surgery for esophageal adenocarcinoma, 1,310 patients developed recurrence and had sufficient follow-up data available. First recurrence was detected at multiple distant sites (n = 469; 37.3%) or at a single distant site (n = 463; 33.7%), whereas isolated local recurrence occurred in 189 (14.4%) patients. Recurrence in the liver-only presented significant earlier (median 9.0 months), whereas recurrence in lung-only (15.2 months) and local-only recurrence (17.8 months) were observed later. Patients with multiple-sites and liver-only recurrence had significant worse median postrecurrence survival (7.4 and 8.3 months, respectively) compared with lung- or local-only recurrence (10.4 and 15.9 months, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights that time to recurrence varies by location and significantly impacts postrecurrence survival outcomes. Multiple sites and liver-only recurrence had the poorest prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19153-8","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:56:37Z","timestamp":1775490997000},"page":"6263-6273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patterns, Timing, and Survival of Recurrence After Surgery for Esophageal and Junctional Adenocarcinoma in the European Multicentre ENSURE Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Lucas","family":"Goense","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie A.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheraz R.","family":"Markar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Klevebro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Johar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Mantziari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00a0Pernilla","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ENSURE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"10110","key":"19153_CR1","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","volume":"390","author":"J Lagergren","year":"2017","unstructured":"Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet. 2017;390(10110):2383\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(17)31462-9. (Epub 2017 Jun 22).","journal-title":"Lancet."},{"issue":"9864","key":"19153_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400\u201312. https:\/\/doi.org\/10.1016\/S0140-6736(12)60643-6.","journal-title":"Lancet."},{"issue":"5","key":"19153_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/SLA.0000000000006018","volume":"278","author":"JA Elliott","year":"2023","unstructured":"Elliott JA, Klevebro F, Mantziari S, et al. Neoadjuvant chemoradiotherapy versus chemotherapy for the treatment of locally advanced esophageal adenocarcinoma in the European multicenter ENSURE study. Ann Surg. 2023;278(5):692\u2013700. https:\/\/doi.org\/10.1097\/SLA.0000000000006018. (Epub 2023 Jul 20).","journal-title":"Ann Surg."},{"issue":"34","key":"19153_CR4","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1200\/JCO.2013.51.7250","volume":"31","author":"K Sudo","year":"2013","unstructured":"Sudo K, Taketa T, Correa AM, et al. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol. 2013;31(34):4306\u201310. https:\/\/doi.org\/10.1200\/JCO.2013.51.7250. (Epub 2013 Oct 21).","journal-title":"J Clin Oncol."},{"issue":"9","key":"19153_CR5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(15)00040-6. (Epub 2015 Aug 5).","journal-title":"Lancet Oncol."},{"issue":"1","key":"19153_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/bjs.9959","volume":"103","author":"WB Robb","year":"2016","unstructured":"Robb WB, Messager M, Dahan L, et al. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone. Br J Surg. 2016;103(1):117\u201325. https:\/\/doi.org\/10.1002\/bjs.9959. (Epub 2015 Oct 29).","journal-title":"Br J Surg."},{"issue":"12","key":"19153_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/bjs\/znac290","volume":"109","author":"M Pape","year":"2022","unstructured":"Pape M, Vissers PAJ, Bertwistle D, et al. Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer. Br J Surg. 2022;109(12):1264\u201373. https:\/\/doi.org\/10.1093\/bjs\/znac290.","journal-title":"Br J Surg."},{"issue":"suppl 5","key":"19153_CR8","doi-asserted-by":"publisher","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","volume":"27","author":"F Lordick","year":"2016","unstructured":"Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v50\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdw329.","journal-title":"Ann Oncol."},{"issue":"3","key":"19153_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/icvts\/ivaa116","volume":"31","author":"D Schizas","year":"2020","unstructured":"Schizas D, Mylonas KS, Kapsampelis P, et al. Patients undergoing surgery for oligometastatic oesophageal cancer survive for more than 2 years: bootstrapping systematic review data. Interact Cardiovasc Thorac Surg. 2020;31(3):299\u2013304. https:\/\/doi.org\/10.1093\/icvts\/ivaa116.","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"19153_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.radonc.2020.09.042","volume":"154","author":"J Li","year":"2021","unstructured":"Li J, Wen Y, Xiang Z, et al. Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer. Radiother Oncol. 2021;154:201\u20136. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.042. (Epub 2020 Sep 25).","journal-title":"Radiother Oncol."},{"issue":"5","key":"19153_CR11","doi-asserted-by":"publisher","first-page":"e1035","DOI":"10.1097\/SLA.0000000000005378","volume":"277","author":"JA Elliott","year":"2023","unstructured":"Elliott JA, Markar SR, Klevebro F, et al. An international multicenter study exploring whether surveillance after esophageal cancer surgery impacts oncological and quality of life outcomes (ENSURE). Ann Surg. 2023;277(5):e1035\u201344. https:\/\/doi.org\/10.1097\/SLA.0000000000005378. (Epub 2022 Jan 27).","journal-title":"Ann Surg."},{"key":"19153_CR12","unstructured":"Burgart LJ, Chopp WV, Jain D. Protocol for the examination of specimens from patients with carcinoma of the esophagus. College of American Pathologists. Accessed April 2024. https:\/\/documents.cap.org\/protocols\/Esophagus_4.2.0.0.REL_CAPCP.pdf"},{"issue":"Suppl 3","key":"19153_CR13","doi-asserted-by":"publisher","first-page":"S1292","DOI":"10.1245\/s10434-015-4840-5","volume":"22","author":"K Parry","year":"2015","unstructured":"Parry K, Visser E, van Rossum PS, et al. Prognosis and treatment after diagnosis of recurrent esophageal carcinoma following esophagectomy with curative intent. Ann Surg Oncol. 2015;22(Suppl 3):S1292\u2013300. https:\/\/doi.org\/10.1245\/s10434-015-4840-5. (Epub 2015 Sep 3).","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"19153_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/SLA.0000000000005638","volume":"276","author":"MC Kalff","year":"2022","unstructured":"Kalff MC, Henckens SPG, Voeten DM, et al. Recurrent disease after esophageal cancer surgery: a substudy of the Dutch Nationwide Ivory Study. Ann Surg. 2022;276(5):806\u201313. https:\/\/doi.org\/10.1097\/SLA.0000000000005638. (Epub 2022 Jul 26).","journal-title":"Ann Surg."},{"issue":"12","key":"19153_CR15","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1245\/s10434-011-1747-7","volume":"18","author":"H Miyata","year":"2011","unstructured":"Miyata H, Yamasaki M, Kurokawa Y, et al. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18(12):3353\u201361. https:\/\/doi.org\/10.1245\/s10434-011-1747-7. (Epub 2011 May 3).","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"19153_CR16","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s00268-022-06608-8","volume":"46","author":"K Matsui","year":"2022","unstructured":"Matsui K, Kawakubo H, Matsuda S, et al. Clinical features of recurrence pattern with lung metastasis after radical esophagectomy for thoracic esophageal cancer. World J Surg. 2022;46(9):2270\u20139. https:\/\/doi.org\/10.1007\/s00268-022-06608-8. (Epub 2022 Jun 16).","journal-title":"World J Surg."},{"issue":"1","key":"19153_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jjco\/hyw141","volume":"47","author":"J Kanamori","year":"2017","unstructured":"Kanamori J, Aokage K, Hishida T, et al. The role of pulmonary resection in tumors metastatic from esophageal carcinoma. Jpn J Clin Oncol. 2017;47(1):25\u201331. https:\/\/doi.org\/10.1093\/jjco\/hyw141. (Epub 2016 Sep 21).","journal-title":"Jpn J Clin Oncol."},{"issue":"4","key":"19153_CR18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s12029-023-00929-0","volume":"54","author":"F Grou-Boileau","year":"2023","unstructured":"Grou-Boileau F, Tankel J, Nevo Y, et al. Locoregional recurrence of esophageal cancer treated with curative intent local salvage therapy: A single center experience. J Gastrointest Cancer. 2023;54(4):1292\u20139. https:\/\/doi.org\/10.1007\/s12029-023-00929-0. (Epub 2023 Mar 29).","journal-title":"J Gastrointest Cancer."},{"key":"19153_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejca.2022.09.035","volume":"177","author":"C Panje","year":"2022","unstructured":"Panje C, Hayoz S, Eisterer W, et al. Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75\/08 trial. Eur J Cancer. 2022;177:186\u201393. https:\/\/doi.org\/10.1016\/j.ejca.2022.09.035. (Epub 2022 Oct 5).","journal-title":"Eur J Cancer."},{"issue":"5","key":"19153_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/SLA.0000000000002895","volume":"268","author":"LM O'Neill","year":"2018","unstructured":"O\u2019Neill LM, Guinan E, Doyle SL, et al. The RESTORE randomized controlled trial: Impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship. Ann Surg. 2018;268(5):747\u201355.","journal-title":"Ann Surg."},{"issue":"3","key":"19153_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41588-018-0331-5","volume":"51","author":"AM Frankell","year":"2019","unstructured":"Frankell AM, Jammula S, Li X, et al. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic. Nat Genet. 2019;51(3):506\u201316. https:\/\/doi.org\/10.1038\/s41588-018-0331-5. (Epub 2019 Feb 4).","journal-title":"Nat Genet."},{"issue":"4","key":"19153_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/PAS.0000000000000356","volume":"39","author":"AD Singhi","year":"2015","unstructured":"Singhi AD, Foxwell TJ, Nason K, et al. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival. Am J Surg Pathol. 2015;39(4):487\u201395. https:\/\/doi.org\/10.1097\/PAS.0000000000000356. (Epub 2015 Apr 3).","journal-title":"Am J Surg Pathol."},{"key":"19153_CR23","doi-asserted-by":"publisher","unstructured":"Li S, Hoefnagel SJM, Krishnadath KK, et al. molecular biology and clinical management of esophageal adenocarcinoma. Cancers (Basel). 2023;15(22):5410. https:\/\/doi.org\/10.3390\/cancers15225410. Epub 2023 Nov 14.","DOI":"10.3390\/cancers15225410"},{"key":"19153_CR24","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00420","volume":"6","author":"BM Huffman","year":"2022","unstructured":"Huffman BM, Aushev VN, Budde GL, et al. Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers. JCO Precis Oncol. 2022;6:e2200420.","journal-title":"JCO Precis Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19153-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:54Z","timestamp":1780761114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19153-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["19153"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19153-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}